Skip to main content

Recent advances in systemic therapy

Paul Ellis

  1. Human epidermal growth factor receptor (HER)2 over-expression is associated with a shortened disease-free interval and poor survival. Although the addition of trastuzumab to chemotherapy in the first-line sett...

    Authors: Phuong Khanh H Morrow, Francisco Zambrana and Francisco J Esteva
    Citation: Breast Cancer Research 2009 11:207
  2. The key to optimising our approach in early breast cancer is to individualise care. Each patient has a tumour with innate features that dictate their chance of relapse and their responsiveness to treatment. Of...

    Authors: Catherine Oakman, Silvia Bessi, Elena Zafarana, Francesca Galardi, Laura Biganzoli and Angelo Di Leo
    Citation: Breast Cancer Research 2009 11:205